Mary Haak-Frendscho is the founder of Spotlight Therapeutics. Spotlight Therapeutics has raised $67M in total funding. Latest round: Series B.
Mary Haak-Frendscho is the former CEO and co-founder of Spotlight Therapeutics, a CRISPR-based gene editing biotechnology company she launched in 2020. She led the company through two funding rounds totaling $66.5 million before its operations were folded into Stipple Bio.
Full founder directory · Investor directory · Company funding database · Fundraising library